Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Feb 10, 2012

NEW YORK (GenomeWeb News) – Pacific Biosciences has named Terry Pizzie to be VP of global sales, promoting him from his previous position as VP of the firm's Europe division. Before joining PacBio, Pizzie was director of global commercial operations for Genetix, he was senior VP of commercial operations at Biacore, and he was VP of European commercial operations at Applied Biosystems.


Randy Scott will lead a new subsidiary at Genomic Health that will focus on integrating genomic data into clinical practice for patients with common and rare genetic conditions. Scott will step down as Genomic Health's executive chairman but will remain a board member, while CEO Kim Popovits will assume the role of chairman.

Scott is a founder of Genomic Health and was previously CEO of the company. He also founded Incyte, where he served in various positions including chief scientific officer; and has served as senior director of research at Invitron. He holds a BS in chemistry from Emporia State University and a PhD in biochemistry from the University of Kansas.

Genomic Health has also appointed Julian Baker to be lead independent director. Baker has served on the firm's board since 2001 and is a managing partner at Baker Brothers Investments. He is also a director of Incyte, Neurogen, Theravance, and Trimeris. He holds a BA in social studies from Harvard University.


PerkinElmer has tapped Peter Barrett, currently a partner at Atlas Venture, to serve on its board of directors. Barrett was a co-founder, executive VP and chief business officer at Celera Genomics, and in the 1980s and 1990s he held senior management positions at Perkin-Elmer, the predecessor of Applera that is not associated with PerkinElmer.


Anagnotics has appointed several new members to its expert advisory council including Jörg Hoheisel, head of the Division of Functional Genome Analysis of the German Cancer Research Center (DKFZ) in Heidelberg, and Harald Kessler, director of the Laboratory and Research Unit for Molecular Diagnostics of Pathogens at the Medical University of Graz.


Proteros Biostructures has appointed Klaus Hinterding to be chief scientific officer and a member of its management board. Hinterding formerly was Life Cycle leader at Roche, a researcher at Novartis, and a post-doctoral fellow at Harvard University.


Accelrys said in a filing with the US Securities and Exchange Commission last week that Bruce Pasternack has resigned from the firm's board of directors, effective immediately. The company cited personal reasons for his resignation.


Rockefeller University geneticist and microbiologist Norton Zinder died last week after a long illness at the age of 83. Zinder's research focused on the genetics of bacteria and the properties of bacteriophage genomes, and he spent his entire research career at Rockefeller University.


The University of New England has appointed Dan Brazeau to be founding director of the UNE Genomics, Analytics, and Proteomics core. The core facility was funded in part by the Maine Technology Asset Fund and UNE's College of Pharmacy. Brazeau has 13 years of experience directing academic multiuser core facilities at the University of Buffalo's Pharmaceutical Genetics Laboratory and the University of Florida's Genetic Analysis Laboratory.


Startup Genome Designs has announced new members of its management team. Natalia Alexandrova will serve as the company's CEO. She was previously the marketing director of Ariadne Genomics and has also served as marketing director of Aladdin.

Evgeni Selkov is the company's chief scientific officer. Previously he was the founder and CEO of EMP Project. He was also a co-founder and senior scientific officer at Encyclopedia Genomica and a senior scientist of mathematics and computer science at Argonne National Laboratory.


Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.